Ozempic Launched In India For Type 2 Diabetes Treatment: Check Cost, Should You Take It For Weight Loss?
Bloomberg • 12/13/2025 • Last cited 12/14/2025
Summary
Ozempic has been launched in India as a treatment for Type 2 diabetes, with discussions around its potential use for weight loss. According to Bloomberg, the cost and suitability of the medication for weight management are being evaluated.
Lindy Score Breakdown
35
Age (0-35)
33 days
40
Velocity (0-40)
1 source (low traction)
8
Tier (0-10)
Bloomberg
0
Breadth (0-15)
1 unique
Total Score83/100
Score BreakdownRisk 35
Source Reputation: Moderate trust (8/20 pts)
Consensus: Single source - no independent confirmation yet
Age: 33 days - proven survivor
Stories gain Lindy status through source reputation, network consensus, and time survival.
Anti-Lindy Similar stories
India Open Badminton: PV Sindhu Out, Kidambi Srikanth Advances To 2nd Round
Bloomberg • 1 day ago
Stocks To Watch Today: ICICI Lombard, Tata Elxsi, Endurance Tech, NLC India, Paytm, Just Dial
Bloomberg • 2 days ago
India, EU Teams Engaged To Resolve Contentious Issues Of FTA, Says
Bloomberg • 1 day ago
Why I'm Leaving X: LinkedIn Post Takes Aim At Elon Musk, AI And Cost To Society
Bloomberg • 2 days ago
Bharat Coking Coal IPO Allotment: Steps To Check Status Online, Latest GMP And Other Key Details
Bloomberg • 2 days ago
Apple iPhone 18 Display Specs Tipped; Pro Models To Get Under-Display Face ID
Bloomberg • 1 day ago
Explained: US Credit Card Competition Bill And How It Can Impact Visa, Mastercard
Bloomberg • 2 days ago
Ola Electric Announces Expansion Of 4680 Bharat Cell Platform
Bloomberg • 1 day ago
IOC, BPCL Announce Second Oil Discovery In Abu Dhabi's Onshore Block, Boosting India's Energy Security
Bloomberg • 1 day ago
Samsung Galaxy S26 Ultra: Top 7 Upgrades To Look Out For
Bloomberg • 2 days ago